Carl Hansen, AbCellera CEO
Updated: Tale of two ‘Abs’: AbbVie partners with antibody biotech AbCellera, but keeps details under wraps
AbbVie has signed a multi-year deal with Vancouver-based antibody biotech AbCellera, it announced Thursday morning.
However, outside of that, the duo gave few details about …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.